Safety and Efficacy of Apixaban Use in Peritoneal Dialysis: A Review of the Literature

阿哌沙班 医学 腹膜透析 终末期肾病 重症监护医学 人口 透析 华法林 内科学 血液透析 心房颤动 拜瑞妥 环境卫生
作者
Armaghan Amani,Caitlin M. Fellers,Antoinette Eyebe,Alyssa Hall,Meredith L. Howard
出处
期刊:The Journal of pharmacy technology [SAGE]
卷期号:37 (3): 147-151 被引量:4
标识
DOI:10.1177/8755122520988728
摘要

Objective: To review the safety and efficacy of apixaban for the treatment of nonvalvular atrial fibrillation or venous thromboembolism in patients receiving peritoneal dialysis (PD). Data Sources: A PubMed and MEDLINE search was conducted through December 2020 using the following keywords and Medical Subject Headings (MeSH) terms alone or in various combinations: apixaban, peritoneal dialysis, continuous ambulatory peritoneal dialysis, end-stage renal disease, and hemodialysis. Study Selection and Data Extraction: English-language studies evaluating clinical outcomes pertaining to the use of apixaban in end stage renal disease (ESRD), which included patients receiving peritoneal dialysis were eligible for inclusion. Data Synthesis: Four studies were identified that met inclusion for this review, all retrospective in nature. These studies compared the safety and efficacy of apixaban with standard therapy in ESRD included patients on dialysis, with a very limited number of subjects receiving PD. In these studies, apixaban was shown to be potentially safer and more effective than warfarin. Outcomes did not differentiate between patients receiving PD or not. Conclusions: Use of apixaban in patients receiving PD may be safe and effective based on data from limited patients. Pharmacokinetics and pharmacodynamics of apixaban in the PD setting is an important question that clinicians should consider with use of this medication in the ESRD population. More studies focusing on the PD population are needed to better assess the use of apixaban in this understudied population.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
海绵宝宝发布了新的文献求助10
1秒前
1秒前
SKinner发布了新的文献求助10
2秒前
gqp完成签到,获得积分10
3秒前
3秒前
快乐东蒽完成签到,获得积分10
4秒前
4秒前
sunsun发布了新的文献求助10
5秒前
科目三应助活力千青采纳,获得10
5秒前
6秒前
斯文败类应助小Q啊啾采纳,获得10
6秒前
汉堡包应助小Q啊啾采纳,获得10
6秒前
7秒前
今后应助小鳄鱼采纳,获得10
7秒前
idol完成签到,获得积分20
7秒前
7秒前
7秒前
Jay发布了新的文献求助10
7秒前
胡图图完成签到,获得积分10
8秒前
8秒前
英俊的铭应助冰糖胡芦采纳,获得10
8秒前
丰富赛凤发布了新的文献求助30
9秒前
5年科研3年毕业完成签到,获得积分10
9秒前
滴滴哒完成签到,获得积分20
9秒前
zzz627发布了新的文献求助10
9秒前
嘀嘀咕咕完成签到,获得积分20
10秒前
LL发布了新的文献求助10
10秒前
ljs完成签到,获得积分10
10秒前
zero灬完成签到,获得积分10
10秒前
kento发布了新的文献求助30
11秒前
闪电小超人完成签到,获得积分10
11秒前
WPSH完成签到,获得积分10
11秒前
11秒前
苏打水发布了新的文献求助10
12秒前
顾矜应助失眠冬亦采纳,获得10
12秒前
小镇的废物完成签到,获得积分10
13秒前
牛小牛完成签到,获得积分10
13秒前
顺遂发布了新的文献求助10
13秒前
左右不为难完成签到,获得积分10
13秒前
13秒前
高分求助中
Sustainability in Tides Chemistry 2000
The ACS Guide to Scholarly Communication 2000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
Pharmacogenomics: Applications to Patient Care, Third Edition 800
A Dissection Guide & Atlas to the Rabbit 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3078453
求助须知:如何正确求助?哪些是违规求助? 2731120
关于积分的说明 7517197
捐赠科研通 2379609
什么是DOI,文献DOI怎么找? 1261760
科研通“疑难数据库(出版商)”最低求助积分说明 611719
版权声明 597349